Patent · US Active

Heterocyclic compound

US9428470B2 · kind B2 · utility

1Cited by

2References

3Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Zenichi Ikeda · Yokohama, JP
Minoru Sasaki · Yokohama, JP
Keiko Kakegawa · Yokohama, JP
Fumiaki Kikuchi · Yokohama, JP
Yoichi Nishikawa · Yokohama, JP

Key dates

Filing date	Feb 11, 2015
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Feb 11, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.Specifically, a compound represented by the following formula (I):wherein each symbol is as defined herein,or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.